Health Catalyst, Inc.
HCATFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
307
Cost of Revenue
166
Gross Profit
141
Gross Margin
45.9%
Operating Income
-70
Operating Margin
-22.8%
Net Income
-70
Net Margin
-22.7%
EPS (Basic)
$-1.15
EPS (Diluted)
$-1.15
EBITDA
-11
EBITDA Margin
-3.5%
2023
12/31/2023
Revenue
296
Cost of Revenue
164
Gross Profit
132
Gross Margin
44.5%
Operating Income
-127
Operating Margin
-42.9%
Net Income
-118
Net Margin
-39.9%
EPS (Basic)
$-2.09
EPS (Diluted)
$-2.09
EBITDA
-68
EBITDA Margin
-23.1%
2022
12/31/2022
Revenue
276
Cost of Revenue
143
Gross Profit
133
Gross Margin
48.2%
Operating Income
-140
Operating Margin
-50.7%
Net Income
-137
Net Margin
-49.7%
EPS (Basic)
$-2.56
EPS (Diluted)
$-2.54
EBITDA
-83
EBITDA Margin
-30.0%
2021
12/31/2021
Revenue
242
Cost of Revenue
124
Gross Profit
118
Gross Margin
48.6%
Operating Income
-144
Operating Margin
-59.4%
Net Income
-153
Net Margin
-63.3%
EPS (Basic)
$-3.23
EPS (Diluted)
$-3.23
EBITDA
-102
EBITDA Margin
-42.0%
2020
12/31/2020
Revenue
189
Cost of Revenue
98
Gross Profit
91
Gross Margin
48.1%
Operating Income
-96
Operating Margin
-50.9%
Net Income
-115
Net Margin
-60.9%
EPS (Basic)
$-2.91
EPS (Diluted)
$-2.91
EBITDA
-86
EBITDA Margin
-45.5%